247 related articles for article (PubMed ID: 23921511)
1. Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.
Zhang Z; Zhu Y; Lai Y; Wu X; Feng Z; Yu Y; Bast RC; Wan X; Xi X; Feng Y
Int J Oncol; 2013 Oct; 43(4):1194-204. PubMed ID: 23921511
[TBL] [Abstract][Full Text] [Related]
2. OCT4 mediates FSH-induced epithelial-mesenchymal transition and invasion through the ERK1/2 signaling pathway in epithelial ovarian cancer.
Liu L; Zhang J; Fang C; Zhang Z; Feng Y; Xi X
Biochem Biophys Res Commun; 2015 Jun; 461(3):525-32. PubMed ID: 25911324
[TBL] [Abstract][Full Text] [Related]
3. Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.
Yang X; Wang J; Li WP; Jin ZJ; Liu XJ
Int J Clin Exp Pathol; 2015; 8(6):6716-23. PubMed ID: 26261554
[TBL] [Abstract][Full Text] [Related]
4. The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells.
Lai Y; Zhang X; Zhang Z; Shu Y; Luo X; Yang Y; Wang X; Yang G; Li L; Feng Y
Int J Oncol; 2013 Feb; 42(2):776-84. PubMed ID: 23254909
[TBL] [Abstract][Full Text] [Related]
5. Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer.
Belotte J; Fletcher NM; Alexis M; Morris RT; Munkarah AR; Diamond MP; Saed GM
Reprod Sci; 2015 Jan; 22(1):38-46. PubMed ID: 25038052
[TBL] [Abstract][Full Text] [Related]
6. FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5.
Huang Y; Jin H; Liu Y; Zhou J; Ding J; Cheng KW; Yu Y; Feng Y
Endocr Relat Cancer; 2011 Feb; 18(1):13-26. PubMed ID: 20943720
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor via Nrf2 and HIF1α signaling in human epithelial ovarian cancer.
Zhang Z; Wang Q; Ma J; Yi X; Zhu Y; Xi X; Feng Y; Jin Z
Oncol Rep; 2013 Apr; 29(4):1429-34. PubMed ID: 23404377
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
9. Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.
Perez-Juarez CE; Arechavaleta-Velasco F; Mendez C; Díaz-Cueto L
Med Oncol; 2020 May; 37(7):59. PubMed ID: 32474861
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
11. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
Yan ZY; Sun XC
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
[No Abstract] [Full Text] [Related]
12. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
13. MiR-26b/KPNA2 axis inhibits epithelial ovarian carcinoma proliferation and metastasis through downregulating OCT4.
Lin J; Zhang L; Huang H; Huang Y; Huang L; Wang J; Huang S; He L; Zhou Y; Jia W; Yun J; Luo R; Zheng M
Oncotarget; 2015 Sep; 6(27):23793-806. PubMed ID: 26204489
[TBL] [Abstract][Full Text] [Related]
14. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.
Chefetz I; Alvero AB; Holmberg JC; Lebowitz N; Craveiro V; Yang-Hartwich Y; Yin G; Squillace L; Gurrea Soteras M; Aldo P; Mor G
Cell Cycle; 2013 Feb; 12(3):511-21. PubMed ID: 23324344
[TBL] [Abstract][Full Text] [Related]
15. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
Lee S; Wottrich S; Bonavida B
Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
18. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
19. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
20. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
Qin S; Li Y; Cao X; Du J; Huang X
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
